Sickle cell-induced ischemic priapism

References

• Addis, G., Spector, R., Shaw, E., Musumadi, L., & Dhanda, C. (2007). The physical, social and psychological impact of priapism on adult males with sickle cell disorder. Chronic Illness, 3, 145–154.10.1177/1742395307081505
   Google Scholar
• Adediran, A., Wright, K., Akinbami, A., Dosunmu, A., Oshinaike, O., Osikomaiya, B., ... Ojelabi, O. (2013). Prevalence of priapism and its awareness amongst male homozygous sickle cell patients in Lagos, Nigeria. Advances in Urology, 2013, 1–4.10.1155/2013/890328
   Google Scholar
• Adeyoju, A. B., Olujohungbe, A. B., Morris, J., Yardumian, A., Bareford, D., Akenova, A., ... O'Reilly, P. H. (2002). Priapism in sickle-cell disease; incidence, risk factors and complications – an international multicentre study. BJU International, 90, 898–902.10.1046/j.1464-410X.2002.03022.x
   Google Scholar
• Andersson, K. (2001). Pharmacology of penile erection. Pharmacological Reviews, 53, 417–450.
   Google Scholar
• Andersson, K. E., & Wagner, G. (1995). Physiology of penile erection. Physiological Reviews, 75, 191–236.
   Google Scholar
• Anele, U. A., & Burnett, A. L. (2015). Erectile dysfunction after sickle cell disease–associated recurrent ischemic priapism: Profile and risk factors. The Journal of Sexual Medicine, 12, 713–719.10.1111/jsm.12816
   Google Scholar
• Anele, U. A., Le, B. V., Resar, L. M., & Burnett, A. L. (2015). How I treat priapism. Blood, 125, 3551–3558.
   Google Scholar
• Anele, U. A., Morrison, B. F., & Burnett, A. L. (2015). Molecular pathophysiology of priapism: Emerging targets. Current Drug Targets, 16, 474–483.10.2174/1389450115666141111111842
   Google Scholar
• Bennett, N., & Mulhall, J. (2008). Sickle cell disease status and outcomes of African-American men presenting with priapism. The Journal of Sexual Medicine, 5, 1244–1250.
   Google Scholar
• Berger, R., Billups, K., Brock, G., Broderick, G. A., Dhabuwala, C. B., Goldstein, I., ... Steers, W. (2001). Report of the american foundation for urologic disease (AFUD) thought leader panel for evaluation and treatment of priapism. International Journal of Impotence Research, 13, S39–S43.
   Google Scholar
• Bertolotto, M., Quaia, E., Mucelli, F. P., Ciampalini, S., Forgács, B., & Gattuccio, I. (2003). Color Doppler imaging of posttraumatic priapism before and after selective embolization. RadioGraphics, 23, 495–503.10.1148/rg.232025077
   Google Scholar
• Bertolotto, M., Zappetti, R., Pizzolato, R., & Liguori, G. (2008). Color Doppler appearance of penile cavernosal-spongiosal communications in patients with high-flow priapism. Acta Radiologica, 49, 710–714.10.1080/02841850802027026
   Google Scholar
• Bertram, R. A., Carson, 3rd., C. C., & Webster, G. D. (1985). Implantation of penile prostheses in patients impotent after priapism. Urology, 26, 325–327.10.1016/0090-4295(85)90176-1
   Google Scholar
• Bettocchi, C., Ditonno, P., Palumbo, F., Lucarelli, G., Garaffa, G., Giammusso, B., & Battaglia, M. (2008). Penile prosthesis: What should we do about complications? Advances in Urology, 2008(5), 1–5.10.1155/2008/573560
   Google Scholar
• Bivalacqua, T. J., & Burnett, A. L. (2006). Priapism: New concepts in the pathophysiology and new treatment strategies. Current Urology Reports, 7, 497–502.10.1007/s11934-006-0061-6
   Google Scholar
• Bivalacqua, T. J., Musicki, B., Hsu, L. L., Gladwin, M. T., Burnett, A. L., & Champion, H. C. (2009). Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. The Journal of Sexual Medicine, 6, 2494–2504.10.1111/j.1743-6109.2009.01359.x
   Google Scholar
• Bivalacqua, T. J., Musicki, B., Kutlu, O., & Burnett, A. L. (2012). New insights into the pathophysiology of sickle cell disease‐associated priapism. The Journal of Sexual Medicine, 9, 79–87.10.1111/j.1743-6109.2011.02288.x
   Google Scholar
• Brant, W., Garcia, M., Bella, A., Chi, T., & Lue, T. (2009). T-Shaped shunt and intracavernous tunneling for prolonged ischemic priapism. The Journal of Urology, 181, 1699–1705.10.1016/j.juro.2008.12.021
   Google Scholar
• Broderick, G. A. (2012). Priapism and sickle-cell anaemia: Diagnosis and nonsurgical therapy. The Journal of Sexual Medicine, 9, 88–103.
   Google Scholar
• Broderick, G. A., & Harkaway, R. (1994). Pharmacologic erection: Time-dependent changes in the corporal environment. International Journal of Impotence Research, 6, 9–16.
   Google Scholar
• Broderick, G. A., Kadioglu, A., Bivalacqua, T. J., Ghanem, H., Nehra, A., & Shamloul, R. (2010). Priapism: Pathogenesis, epidemiology, and management. The Journal of Sexual Medicine, 7, 476–500.10.1111/j.1743-6109.2009.01625.x
   Google Scholar
• Burnett, A. L. (2003). Pathophysiology of priapism: Dysregulatory erection physiology thesis. The Journal of Urology, 170, 26–34.10.1097/01.ju.0000046303.22757.f2
   Google Scholar
• Burnett, A. L., & Bivalacqua, T. J. (2007). Priapism: Current principles and practice. Urologic Clinics of North America, 34, 631–642.10.1016/j.ucl.2007.08.006
   Google Scholar
• Burnett, A. L., & Bivalacqua, T. J. (2008). Glucose-6-phosphate dehydrogenase deficiency: An etiology for idiopathic priapism? The Journal of Sexual Medicine, 5, 237–240.10.1111/j.1743-6109.2007.00631.x
   Google Scholar
• Burnett, A. L., & Bivalacqua, T. J. (2011). Priapism: New concepts in medical and surgical management. Urologic Clinics of North America, 38, 185–194.10.1016/j.ucl.2011.02.005
   Google Scholar
• Burnett, A. L., Bivalacqua, T. J., Champion, H. C., & Musicki, B. (2006a). Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology, 67, 1043–1048.10.1016/j.urology.2005.11.045
   Google Scholar
• Burnett, A. L., Bivalacqua, T. J., Champion, H. C., & Musicki, B. (2006b). Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. The Journal of Sexual Medicine, 3, 1077–1084.
   Google Scholar
• Burnett, A. L., Lowenstein, C. J., Bredt, D. S., Chang, T. S., & Snyder, S. H. (1992). Nitric oxide: A physiologic mediator of penile erection. Science, 257, 401–403.10.1126/science.1378650
   Google Scholar
• Burnett, A. L., & Sharlip, I. D. (2013). Standard operating procedures for priapism. The Journal of Sexual Medicine, 10, 180–194.10.1111/j.1743-6109.2012.02707.x
   Google Scholar
• Champion, H. C., Bivalacqua, T. J., Takimoto, E., Kass, D. A., & Burnett, A. L. (2005). Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proceedings of the National Academy of Sciences, 102, 1661–1666.10.1073/pnas.0407183102
   Google Scholar
• Cherian, J., Rao, A. R., Thwaini, A., Kapasi, F., Shergill, I. S., & Samman, R. (2006). Medical and surgical management of priapism. Postgraduate Medical Journal, 82, 89–94.10.1136/pgmj.2005.037291
   Google Scholar
• Christ, G. J., Richards, S., & Winkler, A. (1997). Integrative erectile biology: The role of signal transduction and cell-to-cell communication in coordinating corporal smooth muscle tone and penile erection. International Journal of Impotence Research, 9, 69–84.10.1038/sj.ijir.3900277
   Google Scholar
• Coombs, P. G., Heck, M., Guhring, P., Narus, J., & Mulhall, J. P. (2012). A review of outcomes of an intravernosal injection therapy programme. BJU International, 110, 1787–1791.
   Google Scholar
• Corbin, J. D., & Francis, S. H. (1999). Cyclic GMP phosphodiesterase-5: Target of sildenafil. Journal of Biological Chemistry, 274, 13729–13732.10.1074/jbc.274.20.13729
   Google Scholar
• Eland, I. A., van der Lei, J., Stricker, B. H., & Sturkenboom, M. J. (2001). Incidence of priapism in the general population. Urology, 57, 970–972.10.1016/S0090-4295(01)00941-4
   Google Scholar
• Emond, A. M., Holman, R., Hayes, R. J., & Serjeant, G. R. (1980). Priapism and impotence in homozygous sickle cell disease. Archives of Internal Medicine, 140, 1434–1437.10.1001/archinte.1980.00330220022011
   Google Scholar
• Feldstein, V. A. (1993). Posttraumatic “high-flow” priapism evaluation with color flow Doppler sonography. Journal of Ultrasound in Medicine, 12, 589–593.
   Google Scholar
• Fournier, Jr., G. R., Juenemann, K. P., Lue, T. F., & Tanagho, E. A. (1987). Mechanisms of venous occlusion during canine penile erection: An anatomic demonstration. Journal of Urology, 137, 163–167.
   Google Scholar
• Furtado, P. S., Costa, M. P., Ribeiro do Prado Valladares, F., Oliveira da Silva, L., Lordêlo, M., Lyra, I., & Barroso, U. (2012). The prevalence of priapism in children and adolescents with sickle cell disease in Brazil. International Journal of Hematology, 95, 648–651.10.1007/s12185-012-1083-0
   Google Scholar
• Goetz, T., & Burnett, A. L. (2014). Prostate cancer risk after anti-androgen treatment for priapism. International Urology and Nephrology, 46, 757–760.10.1007/s11255-013-0583-z
   Google Scholar
• Hakim, L. S., Kulaksizoglu, H., Mulligan, R., Greenfield, A., & Goldstein, I. (1996). Evolving concepts in the diagnosis and treatment of arterial high flow priapism. The Journal of Urology, 155, 541–548.10.1016/S0022-5347(01)66444-9
   Google Scholar
• Hannan, J. L., Albersen, M., Kutlu, O., Gratzke, C., Stief, C. G., Burnett, A. L., … Bivalacqua, T. J. (2013). Inhibition of Rho-kinase improves erectile function, increases nitric oxide signalling and decreases penile apoptosis in a rat model of cavernous nerve injury. Journal of Urology, 189, 115–1161.
   Google Scholar
• Ignarro, L. (1990). Haem-dependent activation of guanylate cyclase and cyclic GMP Formation by endogenous nitric oxide: A unique transduction mechanism for transcellular signaling. Pharmacology & Toxicology, 67(1), 1–7.10.1111/bcpt.1990.67.issue-1
   Google Scholar
• Jesus, L. E., & Dekermacher, S. (2009). Priapism in children: Review of pathophysiology and treatment. Jornal de Pediatria, 85, 194–200.
   Google Scholar
• Jünemann, K. P., Persson-Jünemann, C., & Alken, P. (1990). Pathophysiology of erectile dysfunction. Seminars in Urology, 8, 80–93.
   Google Scholar
• Kato, G. J. (2012). Priapism in sickle‐cell disease: A hematologist’s perspective. The Journal of Sexual Medicine, 9, 70–78.10.1111/j.1743-6109.2011.02287.x
   Google Scholar
• Kato, G. J., Wang, Z., Machado, R. F., Blackwelder, W. C., Taylor, 6th., J. G., & Hazen, S. L. (2009). Endogenous nitric oxide synthase inhibitors in sickle cell disease: Abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology, 145, 506–513.10.1111/bjh.2009.145.issue-4
   Google Scholar
• Kovac, J. R., Mak, S. K., Garcia, M. M., & Lue, T. F. (2013). A pathophysiology-based approach to the management of early priapism. Asian Journal of Andrology, 15, 20–26.10.1038/aja.2012.83
   Google Scholar
• Kumar, V., Fausto, N., Abbas, A., Cotran, R., & Robbins, S. (2004). Robbins and Cotran’s pathologic basis of disease. Philadelphia, PA: Elsevier Saunders.
   Google Scholar
• Levey, H. R., Kutlu, O., & Bivalacqua, T. J. (2012). Medical management of ischemic stuttering priapism: A contemporary review of the literature. Asian Journal of Andrology, 14, 156–163.10.1038/aja.2011.114
   Google Scholar
• Levey, H. R., Segal, R. L., & Bivalacqua, T. J. (2014). Management of priapism: An update for clinicians. Therapeutic Advances in Urology, 6, 230–244.10.1177/1756287214542096
   Google Scholar
• Liao, J. (2002). Blood feud: Keeping hemoglobin from nixing NO. Nature Medicine, 8, 1350–1351.10.1038/nm1202-1350
   Google Scholar
• Lin, C. R., Chow, S., Lau, A., Tu, R., & Lue, T. F. (2002). Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters. International Journal of Impotence Research, 14, 15–24.10.1038/sj.ijir.3900802
   Google Scholar
• Lin, Y. H., Kim, J. J., Stein, N. B., & Khera, M. (2011). Malignant priapism secondary to metastatic prostate cancer: A case report and review of literature. Reviews in Urology, 13, 90–94.
   Google Scholar
• Lionnet, F., Hammoudi, N., Stojanovic, K. S., Avellino, V., Grateau, G., Girot, R., & Haymann, J.-P. (2012). Hemoglobin sickle cell disease complications: A clinical study of 179 cases. Haematologica, 97, 1136–1141.10.3324/haematol.2011.055202
   Google Scholar
• Lue, T. F., Hellstrom, W. J., McAninch, J. W., & Tanagho, E. A. (1986). Priapism: A refined approach to diagnosis and treatment. Journal of Urology, 136, 104–108.
   Google Scholar
• Mantadakis, E., Cavender, J. D., Rogers, Z. R., Ewalt, D. H., & Buchanan, G. R. (1999). Prevalence of priapism in children and adolescents with sickle cell anemia. Journal of Pediatric Hematology/Oncology, 21, 518–522.10.1097/00043426-199911000-00013
   Google Scholar
• Melman, A., Serels, S., & Series, S. (2000). Priapism. International Journal of Impotence Research, 12, S133–S139.10.1038/sj.ijir.3900592
   Google Scholar
• Monga, M., Broderick, G. A., & Hellstrom, W. J. (1996). Priapism in sickle cell disease: The case for early implantation of the penile prosthesis. European Urology, 30, 54–59.
   Google Scholar
• Montague, D. K., Jarow, J., Broderick, G. A., Dmochowski, R. R., Heaton, J. P. W., Lue, T. F., ... Sharlip, I. D. (2003a). American urological association guideline on the management of priapism. The Journal of Urology, 170, 1318–1324.10.1097/01.ju.0000087608.07371.ca
   Google Scholar
• Montague, D. K., Jarow, J., Broderick, G. A., Dmochowski, R. R., Heaton, J. P. W., Lue, T. F., ... Sharlip, I. D. (2003b). Guideline on the management of priapism. American Urological Association Education and Research. Retrieved from https://www.auanet.org/education/guidelines/priapism.cfm
   Google Scholar
• Morrison, B. F., & Burnett, A. L. (2011). Priapism in hematological and coagulative disorders: An update. Nature Reviews Urology, 8, 223–230.10.1038/nrurol.2011.28
   Google Scholar
• Morrison, B. F., & Burnett, A. L. (2012). Stuttering priapism: Insights into pathogenesis and management. Current Urology Reports, 13, 268–276.10.1007/s11934-012-0258-9
   Google Scholar
• Motulsky, A. (1973). Frequency of Sickling Disorders in U.S. Blacks. New England Journal of Medicine, 288, 31–33.10.1056/NEJM197301042880108
   Google Scholar
• Mulhall, J. P., Incrocci, L., Goldstein, I., & Rosen, R. (2011). Cancer and sexual health. NewYork, NY: Springer Science & Business Media.10.1007/978-1-60761-916-1
   Google Scholar
• Nelson, 3rd., J. H., & Winter, C. C. (1977). Priapism: Evolution of management in 48 patients in a 22-year series. Journal of Urology, 117, 455–458.
   Google Scholar
• Nixon, R., O’connor, J., & Milam, D. (2003). Efficacy of shunt surgert for refractory low flow priapism: A report on the incidence of failed detumescence and erectile Dysfunction. The Journal of Urology, 170, 883–886.10.1097/01.ju.0000081291.37860.a5
   Google Scholar
• Nolan, V. G., Wyszynski, D. F., Farrer, L. A., & Steinberg, M. H. (2005). Haemolysis-associated priapism in sickle cell disease. Blood, 106, 3264–3267.
   Google Scholar
• Olujohungbe, A. B., Adeyoju, A., Yardumian, A., Akinyanju, O., Morris, J., Westerdale, N., ... Khoriatry, A. I. (2011). A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: Report of an international randomized control trial—The priapism in sickle cell study. Journal of Andrology, 32, 375–382.10.2164/jandrol.110.010934
   Google Scholar
• Olujohungbe, A., & Burnett, A. L. (2013). How I manage priapism due to sickle cell disease. British Journal of Haematology., 160, 754–765.10.1111/bjh.12199
   Google Scholar
• Pierorazio, P. M., Bivalacqua, T. J., & Burnett, A. L. (2011). Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation. Journal of Andrology, 32, 371–374.10.2164/jandrol.110.011890
   Google Scholar
• Pohl, J., Pott, B., & Kleinhans, G. (1986). Priapism: A three-phase concept of management according to aetiology and prognosis. British Journal of Urology, 58, 113–118.10.1111/bju.1986.58.issue-2-4
   Google Scholar
• Porst, H. (1996). The rationale for prostaglandin E1 in erectile failure: A survey of worldwide experience. Journal of Urology, 155, 802–815.
   Google Scholar
• Prabhakaran, K., Jacobs, B. L., Smaldone, M. C., & Franks, M. E. (2007). Stuttering priapism associated with hereditary spherocytosis. The Canadian Journal of Urology, 14, 3702–3704.
   Google Scholar
• Rajfer, J., Aronson, W. J., Bush, P. A., Dorey, F. J., & Ignarro, L. J. (1992). Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. New England Journal of Medicine, 326, 90–94.10.1056/NEJM199201093260203
   Google Scholar
• Ralph, D. J., Borley, N. C., Allen, C., Kirkham, A., Freeman, A., Minhas, S., Muneer, A. (2010). The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism. BJU International, 106, 1714–1718.10.1111/bju.2010.106.issue-11
   Google Scholar
• Ralph, D. J., Garaffa, G., Muneer, A., Freeman, A., Rees, R., & Christopher, A. N. (2009). The immediate insertion of a penile prosthesis for acute ischaemic priapism. European Urology, 56, 1033–1038.10.1016/j.eururo.2008.09.044
   Google Scholar
• Rees, R. W., Kalsi, J., Minhas, S., Peters, J., Kell, P., & Ralph, D. J. (2002). The management of low-flow priapism with the immediate insertion of a penile prosthesis. BJU International, 90, 893–897.10.1046/j.1464-410X.2002.03058.x
   Google Scholar
• Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, 3rd, R. O., Schechter, A. N., & Gladwin, M. T. (2002). Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383–1389.10.1038/nm1202-799
   Google Scholar
• Salonia, A., Eardley, I., Giuliano, F., Hatzichristou, D., Moncada, I., Vardi, Y., ... Hatzimouratidis, K. (2014). European association of urology guidelines on priapism. European Urology, 65, 480–489.10.1016/j.eururo.2013.11.008
   Google Scholar
• Sauzeau, V., Rolli-Derkinderen, M., Marionneau, C., Loirand, G., & Pacaud, P. (2003). RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. Journal of Biological Chemistry, 278, 9472–9480.10.1074/jbc.M212776200
   Google Scholar
• Segal, R. L., Readal, N., Pierorazio, P. M., Burnett, A. L., & Bivalacqua, T. J. (2013). Corporal Burnett “Snake” surgical maneuver for the treatment of ischemic priapism: Long-term followup. The Journal of Urology, 189, 1025–1029.10.1016/j.juro.2012.08.245
   Google Scholar
• Shalev, M., Staerman, F., Allain, H., Lobel, B., & Saiag, B. (1999). Stimulation of P2y purinoceptors induces, via nitric oxide production, endothelium-dependent relaxation of human isolated corpus cavernosum. The Journal of Urology, 161, 955–959.10.1016/S0022-5347(01)61828-7
   Google Scholar
• Spycher, M., & Hauri, D. (1986). The ultra structure of the erectile tissue in priapism. Journal of Urology, 135, 142–147.
   Google Scholar
• Tausch, T. J., Evans, L. A., & Morey, A. F. (2007). Immediate insertion of a semirigid penile prosthesis for refractory ischemic priapism. Military Medicine, 172, 1211–1212.10.7205/MILMED.172.11.1211
   Google Scholar
• Upadhyay, J., Shekarriz, B., & Dhabuwala, C. B. (1998). Penile implant for intractable priapism associated with sickle cell disease. Urology, 51, 638–639.10.1016/S0090-4295(97)00704-8
   Google Scholar
• Winter, C. C., & McDowell, G. (1988). Experience with 105 patients with priapism: Update review of all aspects. Journal of Urology, 140, 980–983.
   Google Scholar
• Yuan, J., DeSouza, R., Westney, O. L., & Wang, R. (2008). Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian Journal of Andrology, 10, 88–101.10.1111/ajan.2008.10.issue-1
   Google Scholar